Growth status of Iranian children with hemodynamically important congenital heart disease

Mohammad Dalili1, Seyed Mahmood Meraji, Paridokht Davari

  • 1Department of Pediatric Cardiology, Shaheed Rajaei Cardiovascular Medical and Research Center, Tehran University of Medical Sciences, Iran. drdalili@yahoo.com

Acta Medica Iranica
|May 21, 2011
PubMed

Insights

Congenital heart disease (CHD) in Iranian children is linked to significant growth failure. Female children and those with cyanosis showed lower body weights, requiring targeted nutritional and psychosocial support.

Area of Science:

  • Pediatrics
  • Cardiology
  • Growth and Development

Background:

  • Congenital heart disease (CHD) is known to correlate with growth retardation.
  • Understanding growth patterns in pediatric CHD populations is crucial for early intervention.

Purpose of the Study:

  • To investigate the growth condition of Iranian children with significant congenital heart disease (CHD).
  • To compare the growth findings with international research on pediatric CHD.

Main Methods:

  • Studied 469 Iranian children (1 month to 18 years) with important CHD.
  • Excluded infants with prematurity, genetic, or neurological disorders affecting growth.
  • Assessed cardiac conditions via clinical exams, ECG, echocardiography, catheterization, and angiography; measured weight and height against standard charts.

Main Results:

  • All patients exhibited significantly lower body weight and height compared to the normal population.
  • Growth failure was more pronounced in female children's weight.
  • Risk factors for growth failure included large left-to-right shunts, pulmonary hypertension, and cyanosis.

Conclusions:

  • Iranian children with CHD experience growth failure, with specific differences noted compared to global data.
  • Cyanotic patients and female children with CHD require enhanced nutritional and psychosocial support due to lower body weights.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...